Successful oral desensitization with osimertinib following osimertinib-induced fever and hepatotoxicity: a case report
{{output}}
Osimertinib is a standard second-line therapy for patients who develop EGFR Thr790Met resistance mutation after treatment with first-line epidermal growth factor receptor tyrosine kinase inhibitors. Although no other effective targeted treatment option exists ... ...
